Tags Singapore eDevelopment Ltd

Tag: Singapore eDevelopment Ltd

Impact Biomedical initiates Quantum Research Program to solve the Patent Cliff

SGX-listed Singapore eDevelopment Limited's (SeD; SGX:40V) wholly-owned subsidiary Impact Biomedical Inc. ("Impact"), announced today the initiation of Quantum, their research program designed to solve...

Impact Biomedical Achieves COVID-19 Success with Equivir and 3F Biofragrance

Singapore eDevelopment Limited's (SeD; SGX:40V) wholly owned subsidiary Impact Biomedical Inc. has announced proven in vitro success with Equivir and 3F Biofragrance against COVID-19...

Impact Biomedical Announces Publication of COVID-19 Research in Peer-Reviewed Journal

SGX-listed Singapore eDevelopment Limited's (SeD; SGX:40V) wholly owned subsidiary Impact Biomedical Inc. ("Impact Biomedical") announced today that their COVID-19 research with Global Research and...

Impact Biomedical and GRDG Sciences Announce Medical Technology Package Valued at USD 1.39 Billion...

SGX-listed Singapore eDevelopment Limited's (the "Company") (SeD; SGX:40V) wholly owned subsidiary, Impact Biomedical Inc. ("Impact Biomedical"), would like to update its stakeholders on its...

Impact Biomedical’s Majority Owned Next Generation Medical Technologies Valued at USD 592 Million (SGD...

SGX-listed Singapore eDevelopment Ltd's (SeD; SGX:40V) wholly owned subsidiary Impact Biomedical Inc., announced today that their suite of antiviral and medical technologies, co-owned with...

Global BioLife’s new mosquito repellent formula performs well against mosquitos in independent testing

Singapore Exchange-listed Singapore eDevelopment Limited (Stock Code 40V) ("SeD") wishes to announce today that its U.S. biomedical subsidiary, Global BioLife Inc. ("Global BioLife"), has...

Singapore eDevelopment (SGX:40V) Subsidiary, Global BioLife’s 3F Antimicrobial Fragrance Shows Efficacy against Tuberculosis

SINGAPORE - (ACN Newswire) - Singapore Exchange-listed Singapore eDevelopment Limited (Stock Code 40V) ("SeD") wishes to announce today that its U.S. biomedical subsidiary, Global...